Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Novartis
Fish and Richardson
Mallinckrodt
Deloitte
Baxter
US Department of Justice
Medtronic
Argus Health
Julphar
Johnson and Johnson

Generated: February 19, 2018

DrugPatentWatch Database Preview

Cnty Line Pharms Company Profile

« Back to Dashboard

What is the competitive landscape for CNTY LINE PHARMS, and what generic alternatives to CNTY LINE PHARMS drugs are available?

CNTY LINE PHARMS has fifteen approved drugs.

There is one US patent protecting CNTY LINE PHARMS drugs.

There are forty-one patent family members on CNTY LINE PHARMS drugs in thirty-four countries.

Summary for Cnty Line Pharms
International Patents:41
US Patents:1
Tradenames:13
Ingredients:10
NDAs:15

Drugs and US Patents for Cnty Line Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985 DISCN No No ➤ Sign Up ➤ Sign Up
Cnty Line Pharms LIDEX-E fluocinonide CREAM;TOPICAL 016908-003 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Sign Up ➤ Sign Up
Cnty Line Pharms METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride TABLET;ORAL 206840-001 Sep 15, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Cnty Line Pharms CICLOPIROX ciclopirox GEL;TOPICAL 020519-001 Jul 21, 1997 AB RX Yes Yes 7,018,656 ➤ Sign Up Y ➤ Sign Up
Cnty Line Pharms UREX methenamine hippurate TABLET;ORAL 016151-001 Approved Prior to Jan 1, 1982 AB RX No No ➤ Sign Up ➤ Sign Up
Cnty Line Pharms METHYLPHENIDATE HYDROCHLORIDE methylphenidate hydrochloride TABLET;ORAL 206840-003 Sep 15, 2016 AB RX No No ➤ Sign Up ➤ Sign Up
Cnty Line Pharms LIDEX fluocinonide SOLUTION;TOPICAL 018849-001 Apr 6, 1984 AT RX Yes No ➤ Sign Up ➤ Sign Up
Cnty Line Pharms DYNACIN minocycline hydrochloride CAPSULE;ORAL 063067-001 Jul 31, 1990 AB RX No No ➤ Sign Up ➤ Sign Up
Cnty Line Pharms BUTALBITAL, ACETAMINOPHEN AND CAFFEINE acetaminophen; butalbital; caffeine TABLET;ORAL 204984-001 Jan 10, 2017 AA RX No No ➤ Sign Up ➤ Sign Up
Cnty Line Pharms FLUOCINONIDE fluocinonide GEL;TOPICAL 017373-001 Approved Prior to Jan 1, 1982 AB RX Yes No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Cnty Line Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-002 Oct 31, 1985 3,900,481 ➤ Sign Up
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-001 May 24, 1985 4,066,755 ➤ Sign Up
Cnty Line Pharms LIDEX fluocinonide CREAM;TOPICAL 016908-002 Approved Prior to Jan 1, 1982 3,592,930 ➤ Sign Up
Cnty Line Pharms LIDEX fluocinonide OINTMENT;TOPICAL 016909-002 Approved Prior to Jan 1, 1982 4,017,615 ➤ Sign Up
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-001 Oct 31, 1985 4,005,209 ➤ Sign Up
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-003 Aug 1, 1984 4,066,755 ➤ Sign Up
Cnty Line Pharms TRANDATE labetalol hydrochloride TABLET;ORAL 018716-002 Aug 1, 1984 4,012,444 ➤ Sign Up
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-003 Jun 3, 1988 4,642,384 ➤ Sign Up
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988 3,800,481 ➤ Sign Up
Cnty Line Pharms TAMBOCOR flecainide acetate TABLET;ORAL 018830-004 Aug 23, 1988 4,642,384 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Premature patent expirations for CNTY LINE PHARMS

Expiration due to failure to pay maintenance fee

Patent Number Expiration Date
➤ Sign Up ➤ Sign Up

Non-Orange Book US Patents for Cnty Line Pharms

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,026,337 Antimycotic gel having high active compound release ➤ Sign Up
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Harvard Business School
Baxter
Colorcon
US Department of Justice
Boehringer Ingelheim
Merck
Dow
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot